WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

ATC/DDD alterations 2020

ATC alterations 2020

Previous ATC codeATC level name New ATC code
L01XX09miltefosineP01CX04
N02CX07erenumabN02CD01
N02CX08galcanezumabN02CD02

Other ATC alterations 2020

ATC codePrevious ATC level name New ATC level name or new ATC level
A03CB04methylhomatropine and psycholepticshomatropine methylbromide and psycholeptics
B06ABOther hem productsHeme products
B06AB01hematinhemin
G01AX14lactobacillus fermentumlactobacillus
N02CDCalcitonin gene-related peptide (CGRP) antagonists
N06BX21mebicartetramethylglycoluril
V08DA01microspheres of human albuminperflutren, human albumin microspheres
V08DA04microspheres of phospholipidsperflutren, phospholipid microspheres
V08DA05sulfur hexafluoridesulfur hexafluoride, phospholipid microspheres
V08DA06perflubutane polymer microspheresperflubutane, phospholipid microspheres

DDD alterations 2020

ATC codeATC level name Previous DDD New DDD
A10BJ02liraglutide1.2mgP1.5mgP

Last updated: 2019-12-16